Health technology company Sonde Health and Boston-based Mass General Brigham were selected by the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging and Alzheimer’s Disease to lead a pilot study on remote detection of vocal biomarkers and the detection of cognitive impairments.
